LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 62.29 | 84.90 | 253 | 7934 | 0.0319 | 0.1815 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 62.29 | 84.90 | 2908 | 7934 | 0.3665 | 0.7157 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 62.29 | 84.90 | 2899 | 7934 | 0.3654 | 0.7149 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 62.29 | 84.90 | 3056 | 7934 | 0.3852 | 0.7288 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 63.99 | 84.90 | 252 | 8212 | 0.0307 | 0.1793 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 63.99 | 84.90 | 3029 | 8212 | 0.3688 | 0.7193 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 63.99 | 84.90 | 2869 | 8212 | 0.3494 | 0.7052 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 63.99 | 84.90 | 3223 | 8212 | 0.3925 | 0.7356 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 65.70 | 84.90 | 263 | 8484 | 0.0310 | 0.1856 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 65.70 | 84.90 | 3149 | 8484 | 0.3712 | 0.7228 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 65.70 | 84.90 | 2513 | 8484 | 0.2962 | 0.6653 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 65.70 | 84.90 | 3330 | 8484 | 0.3925 | 0.7374 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 67.41 | 84.90 | 235 | 8766 | 0.0268 | 0.1644 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 67.41 | 84.90 | 3227 | 8766 | 0.3681 | 0.7225 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 67.41 | 84.90 | 2266 | 8766 | 0.2585 | 0.6338 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 67.41 | 84.90 | 3416 | 8766 | 0.3897 | 0.7372 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 69.11 | 84.90 | 225 | 8988 | 0.0250 | 0.1559 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 69.11 | 84.90 | 3268 | 8988 | 0.3636 | 0.7207 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 69.11 | 84.90 | 1812 | 8988 | 0.2016 | 0.5763 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 69.11 | 84.90 | 3522 | 8988 | 0.3919 | 0.7400 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 70.81 | 84.90 | 214 | 9132 | 0.0234 | 0.1468 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 70.81 | 84.90 | 3357 | 9132 | 0.3676 | 0.7244 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 70.81 | 84.90 | 1242 | 9132 | 0.1360 | 0.4882 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 70.81 | 84.90 | 3584 | 9132 | 0.3925 | 0.7412 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 72.52 | 84.90 | 236 | 9214 | 0.0256 | 0.1632 | MN20160318_Q02 | C22 |